MS-275 combined with cisplatin exerts synergistic antitumor effects in human esophageal squamous cell carcinoma cells
- 23 March 2020
- journal article
- research article
- Published by Elsevier BV in Toxicology and Applied Pharmacology
- Vol. 395, 114971
- https://doi.org/10.1016/j.taap.2020.114971
Abstract
No abstract availableKeywords
Funding Information
- Central Plains Thousand People Plan of Henan Province (204200510013)
- Henan Natural Science Foundation (182300410377)
- National Natural Science Foundation of China (81272691)
- Key R&D and Promotion Projects in Henan Province (182102310380)
This publication has 43 references indexed in Scilit:
- Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic FunctionsPLOS ONE, 2013
- EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancerBMC Cancer, 2012
- β-Catenin Signaling Increases during Melanoma Progression and Promotes Tumor Cell Survival and ChemoresistancePLOS ONE, 2011
- EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent HepatocarcinogenesisCancer Research, 2011
- The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signalingOncogene, 2011
- Coexpression of Oct4 and Nanog Enhances Malignancy in Lung Adenocarcinoma by Inducing Cancer Stem Cell–Like Properties and Epithelial–Mesenchymal TransdifferentiationCancer Research, 2010
- The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatinCritical Reviews in Toxicology, 2010
- Efficacy of MS-275, a selective inhibitor of class I histone deacetylases, in human colon cancer modelsInternational Journal of Oncology, 2009
- Dietary Calcium and Dairy Modulation of Oxidative Stress and Mortality in aP2-Agouti and Wild-type MiceNutrients, 2009
- HDPR1, a novel inhibitor of the WNT/β-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencingOncogene, 2004